Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 18 Oct 2024 10:59 CEST |
LIFECARE ASA | Lifecare ASA: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 15 Oct 2024 23:05 CEST |
LIFECARE ASA | Lifecare ASA: Public retail offering successfully placed | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of application period | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Oct 2024 07:05 CEST |
LIFECARE ASA | Lifecare presentation at the Diabetes Technology Meeting 2024. | 20103010 Biotechnology | Non-regulatory press releases |
| 14 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Application deadline for applicants using Nordnet webservice | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Oct 2024 15:10 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Oct 2024 07:00 CEST |
LIFECARE ASA | LIFE Study protocol has been finalized for submission to regulatory authorities | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Oct 2024 07:05 CEST |
LIFECARE ASA | LIFE Longevity trial: Biopsy and bacteriological examination confirm no unexpected foreign body reactions after removal of implant | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Launch of public retail offering and commencement of application period | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Oct 2024 11:42 CEST |
LIFECARE ASA | Lifecare ASA: Approval and publication of prospectus | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Oct 2024 08:24 CEST |
LIFECARE ASA | OSLO BØRS – TRADING RESUMPTION WARRANTS | 20103010 Biotechnology | Trading halts |
| 02 Oct 2024 20:57 CEST |
LIFECARE ASA | Lifecare ASA: Announcement of terms of public retail offering | 20103010 Biotechnology | Inside information |
| 02 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA First successful production based on automatization of critical processes | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Oct 2024 08:39 CEST |
LIFECARE ASA | OSLO BØRS – TRADING SUSPENSION WARRANTS | 20103010 Biotechnology | Trading halts |
| 01 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Sep 2024 17:31 CEST |
LIFECARE ASA | Lifecare ASA: Share consolidation (reverse split) and change of par value | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Sep 2024 17:22 CEST |
LIFECARE ASA | Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants and change of ISIN for the shares | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Sep 2024 15:14 CEST |
LIFECARE ASA | Euronext Oslo Børs – Vedtak om opptak til handel – Lifecare ASA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 27 Sep 2024 15:14 CEST |
LIFECARE ASA | Euronext Oslo Børs – Decision on admission to trading – Lifecare ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Sep 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2024 12:15 CEST |
LIFECARE ASA | Lifecare ASA: Re-purchase of shares and warrants completed | 20103010 Biotechnology | Acquisition or disposal of the issuer’s own shares |
| 25 Sep 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Re-purchase of shares and warrants | 20103010 Biotechnology | Acquisition or disposal of the issuer’s own shares |
| 17 Sep 2024 11:00 CEST |
LIFECARE ASA | Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Sep 2024 07:00 CEST |
LIFECARE ASA | LIFE Successfully completes the first patient in the longevity trial after three months | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Sep 2024 14:31 CEST |
LIFECARE ASA | LIFECARE ASA: Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Aug 2024 16:18 CEST |
LIFECARE ASA | Euronext Oslo Børs - Received application for admission to trading – Lifecare ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Aug 2024 16:18 CEST |
LIFECARE ASA | Euronext Oslo Børs - Mottatt søknad om opptak til handel – Lifecare ASA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 30 Aug 2024 15:50 CEST |
LIFECARE ASA | Correction: LIFE: Lifecare ASA Q2 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 27 Aug 2024 07:00 CEST |
LIFECARE ASA | LIFE: Lifecare ASA Q2 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 22 Aug 2024 16:30 CEST |
LIFECARE ASA | Lifecare ASA Q2 2024 presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Aug 2024 07:00 CEST |
LIFECARE ASA | LIFE Successfully completed nine weeks of longevity trials | 20103010 Biotechnology | Non-regulatory press releases |
| 13 Aug 2024 07:00 CEST |
LIFECARE ASA | LIFE: Strategic cooperation to make glucose data more accessible | 20103010 Biotechnology | Inside information |
| 17 Jul 2024 08:00 CEST |
LIFECARE ASA | LIFE Successfully completed four weeks of longevity trials | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Jul 2024 10:07 CEST |
LIFECARE ASA | Lifecare ASA: Share capital increase | 20103010 Biotechnology | Total number of voting rights and capital |
| 02 Jul 2024 17:25 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 Jul 2024 08:00 CEST |
LIFECARE ASA | LIFE: Cleanroom arrived in Hamburg | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Jun 2024 08:00 CEST |
LIFECARE ASA | LIFE: Successfully completed first week of longevity trials | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Jun 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Information about the warrants issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Jun 2024 14:47 CEST |
LIFECARE ASA | Lifecare ASA: Share capital increase and warrants registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 18 Jun 2024 08:00 CEST |
LIFECARE ASA | LIFE Longevity trials in dogs starts today | 20103010 Biotechnology | Non-regulatory press releases |
| 14 Jun 2024 16:31 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 14 Jun 2024 12:17 CEST |
LIFECARE ASA | LIFE: Satisfied with the final results of the Rights Issue | 20103010 Biotechnology | Non-regulatory press releases |
| 14 Jun 2024 12:11 CEST |
LIFECARE ASA | Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Jun 2024 19:21 CEST |
LIFECARE ASA | Lifecare ASA: Preliminary results of the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Jun 2024 14:33 CEST |
LIFECARE ASA | LIFE Successful in-vitro quality testing of sensor | 20103010 Biotechnology | Inside information |
| 13 Jun 2024 08:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of the Subscription Period in the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Jun 2024 10:58 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Jun 2024 10:45 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Jun 2024 08:25 CEST |
LIFECARE ASA | LIFE Improved read out distance for sensor preparing for longevity trials in dogs | 20103010 Biotechnology | Inside information |
| 07 Jun 2024 13:21 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |